Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Supportive care in cancer 2021-08, Vol.29 (8), p.4185-4186
Hauptverfasser:	Rossi, Maura, Gambino, Alessio, Cabras, Marco, Alessio, Manuela, Fusco, Vittorio
Format:	Artikel
Sprache:	eng
Schlagworte:	Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology Bone Density Conservation Agents - adverse effects Bone Neoplasms - drug therapy Bone Neoplasms - secondary Cancer patients Denosumab - adverse effects Diphosphonates - adverse effects Humans Letter to the Editor Medicine Medicine & Public Health Nursing Nursing Research Oncology Osteonecrosis - chemically induced Pain Medicine Patient compliance Rehabilitation Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!